Crossmark

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration

Crossref DOI link: https://doi.org/10.1186/s13024-022-00534-y

Published Online: 2022-04-08

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cervantes González, Alba

Irwin, David J.

Alcolea, Daniel

McMillan, Corey T.

Chen-Plotkin, Alice

Wolk, David

Sirisi, Sònia

Dols-Icardo, Oriol

Querol-Vilaseca, Marta

Illán-Gala, Ignacio

Santos-Santos, Miguel Angel

Fortea, Juan

Lee, Edward B.

Trojanowski, John Q.

Grossman, Murray

Lleó, Alberto

Belbin, Olivia https://orcid.org/0000-0002-6109-6371
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI18/00327, PI20/01330, PI20/01473, C18/00011)

Centro de Investigación Biomédica en Red-Enfermedades Neurodegenerativas (Programa 1)

Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR PROD 2019 00088, SLT002/16/00408)

National Institute on Aging (P01AG066597, P30AG072979, U19 AG062418, 1R01AG056850-01A1, R21AG056974, R01AG061566)
License Information

Text and Data Mining valid from 2022-04-08

Version of Record valid from 2022-04-08
More Information

Article History

Received: 13 September 2021

Accepted: 30 March 2022

First Online: 8 April 2022

Declarations

:

: All participants gave written informed consent to participate. The local ethics committee at each center approved the.study.

: Not applicable.

: OB, AL, JF and DA declare a filed patent application (pending) to the European Patent Office for Markers of synaptopathy neurodegenerative disease.

Document is current

Any future updates will be listed below